Form 4 · Filed Mar 5, 2026, 12:00 PM UTC
INDV/Indivior Pharmaceuticals, Inc.
Preblick Ryan — Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | F | other | 87,597 | $32 | $2,801,352 | 230,343 |
| Mar 3, 2026 | M | other | 86,949 | — | — | 317,292 |
| Mar 3, 2026 | M | other | 113,510 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0002014866-26-000006